APRE
Aprea Therapeutics, Inc. · Healthcare
Versant Vantage I, L.P. bought $5.0M of Aprea Therapeutics, Inc.
10% owner
Bought$4,999,995
$15.00Price
333,333Shares
+13%Stake
What APRE did for a copier
Prices for APRE after this filing aren't in yet.
Versant Vantage I, L.P.'s record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Mon, Oct 7. Filed Mon, Oct 7, 3:40 PM ET, during the session. Not investment advice.